TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
KZR

Kezar Life Sciences Inc

Healthcare · Biotechnology

0.175$ +6.1% vs. previous close Closing price · As of: Aug 13, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement KZR
Line item 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – – – – – 100.0% – –
– – – – – – – 15.2% – –
– – – – – – – 100.0% – –
– – – – – – – 1,224.2% – –
– – – – – – – 379.1% – –
– – – – – – – 1,691.8% – –
– – – – – – – -1,591.8% – –
– – – – – – – 22.1% – –
– – – – – – – -1,455.3% – –
– – – – – – – 12.8% – –
– – – – – – – -1,455.3% – –
– – – – – – – -1,417.9% – –

Data as of: August 13, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?